🔎 Trials Near Me

Gara Jalqabaatti › Schizophrenia › Illinois

Qorannoo klinikaalii Schizophrenia Illinois keessatti

Qorannoo 26 Schizophrenia f Illinois keessatti hirmaatuu jiru.

Magaalota Illinois keessatti

Takkalaa qorannoo (Ingiliffa)

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

  • The University of Chicago, Chicago
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07853807

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Evanston Hospital, Evanston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07101094

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

  • Uptown Research Institute, Chicago
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  • Local Institution - 0067, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07686263

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  • Neurocrine Clinical Site, Chicago
  • Neurocrine Clinical Site, Oak Brook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07114874

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Baber Research Group, Naperville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06229210

A Study of Brenipatide in Adult Participants With Schizophrenia

  • Re:Cognition Health - Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07410507

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0175, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07424404

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Naperville
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07105111

52-week Open Label Safety-Tolerability Study

  • Pillar Clinical Research, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • Local Institution - 0122, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 13 hanga 17 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

  • Uptown Research Institute, Chicago
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Local Institution - 0046, Crystal Lake
  • Amr Conventions Research - Illinois, Warrenville
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigator Site, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT05303064

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

  • Uptown Research Institute LLC, Chicago
  • Pillar Clinical Research LLC, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

  • Pillar Clinical Research, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07363577

Transition Care for FEP

  • University of Chicago Ingalls Memorial Hospital, Harvey
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 40 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07713849

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

  • Uptown Research Institute, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07191483

A Study to Evaluate the Effect of KarXT on Urological Safety

  • Uptown Research Institute, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT07221877

CLOZAPINE Response in Biotype-1

  • University of Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT04580134

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  • University of Chicago Medical Center, Chicago
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 40 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 06-Bit-2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

  • Vanda Investigational Site, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 12-Ama-2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

  • Site 5056, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 21 hanga 55 · Saalaa hunda · Haaromfame 26-Mud-2025 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

  • Reviva site, Chicago
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 19-Mud-2024 · NCT05184335

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.